Sodium Chloride
Generic: SODIUM CHLORIDE
Basic Information
Manufacturer
B. Braun Medical Inc.
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS
FDA Set ID
cc14fafd-3dcd-4fc8-bdbd-6f355c375768
Indications & Usage
INDICATIONS AND USAGE This intravenous solution is indicated for use in adults and pediatric patients as a source of electrolytes and water for hydration.
This product is designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.
Consult prescribing information for INDICATIONS AND USAGE of drug additives to be administered in this manner.
This product is designed for use as a diluent and delivery system for intermittent intravenous administration of compatible drug additives.
Consult prescribing information for INDICATIONS AND USAGE of drug additives to be administered in this manner.
Warnings
WARNINGS Solutions containing sodium ions should be used with great care, if at all, in patients with congestive heart failure, severe renal insufficiency, and in clinical states in which there is sodium retention with edema.
In patients with diminished renal function, administration of solutions containing sodium ions may result in sodium retention.
In patients with diminished renal function, administration of solutions containing sodium ions may result in sodium retention.
Adverse Reactions
ADVERSE REACTIONS Reactions which may occur because of the solution or the technique of administration include febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia.
The physician should also be alert to the possibility of adverse reactions to drug additives diluted and administered from the plastic partial fill container.
Prescribing information for drug additives to be administered in this manner should be consulted.
Symptoms may result from an excess or deficit of one or more of the ions present in the solution; therefore, frequent monitoring of electrolyte levels is essential.
Hypernatremia may be associated with edema and exacerbation of congestive heart failure due to the retention of water, resulting in an expanded extracellular fluid volume.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.
The physician should also be alert to the possibility of adverse reactions to drug additives diluted and administered from the plastic partial fill container.
Prescribing information for drug additives to be administered in this manner should be consulted.
Symptoms may result from an excess or deficit of one or more of the ions present in the solution; therefore, frequent monitoring of electrolyte levels is essential.
Hypernatremia may be associated with edema and exacerbation of congestive heart failure due to the retention of water, resulting in an expanded extracellular fluid volume.
If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.